Leverkusen, Germany - Biofrontera AG today entered into an agreement with Biofrontera Inc. to modify the business relationship between the two companies.

Biofrontera AG will focus on capitalizing its existing projects and know-how, while research and development will no longer be a core part of its activities. This revised strategy and the amended agreement with Biofrontera AG's largest customer, Biofrontera Inc., will have a significant impact on the structure of revenues and costs, both of which will be reduced. Biofrontera AG will provide new guidance for 2024 in due course.

Contact:

Tel: +49 (0) 214 87 63 20

Email: ir@biofrontera.com

Web: www.biofrontera.com

(C) 2024 Electronic News Publishing, source ENP Newswire